Global Market for Pain Management Drugs and Devices
상품코드:1382552
리서치사:BCC Research
발행일:2023년 11월
페이지 정보:영문 171 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 통증 관리 약물 및 기기 시장 규모는 2023년 846억 달러에서 예측 기간 동안 5.4%의 CAGR을 나타내고, 2028년 말에는 1,099억 달러 규모에 이를 것으로 예상됩니다.
제품별로는 의약품 부문이 2023년 779억 달러에서 2028년 말 1,006억 달러 규모로 성장해 같은 기간 동안 5.3%의 CAGR을 나타낼 것으로 예상됩니다. 디바이스 부문은 2023년 67억 달러에서 2028년 6.7%의 CAGR을 나타내고, 2028년 92억 달러 규모로 성장할 것으로 예상됩니다.
세계의 통증 관리 약물 및 기기 시장을 조사했으며, 시장 및 기술 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 기술 및 특허 동향, 임상시험 동향, ESG 동향, 경쟁 구도, 주요 기업 개요, 주요 기업 프로파일 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약 및 하이라이트
시장 전망
통증 관리약 및 디바이스 시장 하이라이트
제3장 시장 개요
통증과 통증 치료의 역사
통증에 대한 인식
통증의 유형
급성 통증
만성 통증
통증 평가
주관적
객관적
통증 진단 방법
통증 치료 방법
신체적 통증 치료 모달리티
침 치료 및 지압
아이싱(냉동요법)
관절 운동
시술
마사지
견인
방사선 치료
고주파 신경 절제술 및 경막외경 검사
수술
월풀 욕조(온열 요법)
심리적 통증 요법
바이오피드백
최면
행동 수정/행동 조절
이완 및 스트레스 관리 훈련
영상
자율훈련
심리사회적 개입
주의 분산 및 재구성
제4장 시장 역학
개요
시장 성장 촉진요인
시장 성장 억제요인
시장이 해결해야 할 과제
제5장 시장 내역 : 제품별
시장 개요
시장 점유율과 예측
의약품
마약
비마약
항편두통약
마취제
기타
통증 관리 기기
신경 자극 기기
주입 펌프
절제 기기
제6장 시장 내역 : 용도별
시장 개요
시장 점유율과 예측
근골격 통증
수술후 통증
신경병증 통증
암성 통증
편두통
기타
HIV/에이즈
화상
치통
제7장 시장 내역 : 지역별
시장 개요
시장 점유율 예측
북미
미국
캐나다
유럽
독일
영국
이탈리아
프랑스
기타 유럽
아시아태평양
중국
인도
일본
기타 아시아태평양
기타 지역
제8장 ESG 전개
ESG 개요
통증 관리약 및 디바이스 업계에서의 지속가능성 : ESG 관점
주요 ESG 문제
ESG 순위
통증 관리약 및 디바이스 시장에서의 ESG에 대한 소비자 의식
사례 연구
BCC의 결론
제9장 신기술
개요
오피오이드약 기술 진보
비마약 기술 진보
신경 조절 기기 기술 진보
주입 펌프 기술 진보
통증 관리 동향
약물유전체학
인공지능(AI)에 의한 통증 관리
제10장 임상시험·특허 분석
임상시험 개요
임상시험 분석 : 연구 유형별
임상시험 분석 : 현황별
임상시험 분석 : 단계별
임상시험 분석 : 지역별
특허 분석 개요
특허 : 연별
상위 출원인 특허
상위 특허 보유자 특허
특허 : 관할구역별
제11장 경쟁 정보
시장 분석
통증 관리약 시장
통증 관리 기기시장
자금조달
최근 동향 : 주요 기업별
제12장 기업 개요
ABBOTT LABORATORIES
ABBVIE INC
ASSERTIO HOLDINGS INC.
ASTRAZENECA PLC
BOSTON SCIENTIFIC CORP.
ELI LILLY & CO.
ENDO INTERNATIONAL PLC
ENOVIS CORP.
GLAXOSMITHKLINE
GRUNENTHAL GMBH
JOHNSON & JOHNSON
MEDTRONIC PLC
NOVARTIS INTERNATIONAL AG
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
제13장 부록 : 두자어
LSH
영문 목차
영문목차
Highlights:
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
Pharmaceuticals market for pain management drugs and devices is expected to increase from $77.9 billion in 2023 to $100.6 billion by the end of 2028, with a CAGR of 5.3% during the forecast period of 2023-2028.
Medical devices market for pain management drugs and devices is expected to increase from $6.7 billion in 2023 to $9.2 billion by the end of 2028, with a CAGR of 6.7% during the forecast period of 2023-2028.
##img_0A##
Report Scope:
The current report provides detailed analysis of the market for pain management drugs and devices. It highlights the current and future market potential of pain management drugs and devices and gives a detailed analysis of the market's drivers, restraints and challenges. The report also covers market projections for 2028 and provides market rankings for key market players. It also covers the competitive environment and regulatory landscape, and it details the market share of pain management drugs and devices based on product and application. Based on products, the global pain management drugs and devices market is segmented into pharmaceuticals and medical devices. Based on applications, the market is segmented into post-operative pain, neuropathic pain, cancer pain, migraine/headache, musculoskeletal pain and other applications. The report includes company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments.
The market has been divided by geography into North America, Europe, Asia-Pacific and the Rest of the world. The North American region comprises countries such as the U.S. and Canada; Europe includes countries Germany, U.K., Italy, France and the Rest of Europe; Asia-Pacific includes countries China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021, which serve as the historical years; 2022 is the base year; and forecast data is given for 2028.
Not covered in the report are drugs or devices that relieve pain by treating the specific condition or disorder. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Only those disease-specific treatments that involve a relief of the pain symptoms associated with the respective condition are included.
Here is a comparison of a treatment for a disease (in this case, rheumatoid arthritis) that naturally relieves symptoms vs. a treatment for the relief of the pain associated with the disease -
Enbrel: Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
Celebrex: Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.
Report Includes:
44 data tables and 37 additional tables
An overview of the global market for pain management drugs and devices
Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
Assessment of pain, history of pain and pain management, and information on physical pain treatment modalities and psychological pain therapies.
Coverage of emerging technologies in the pain management market, an assessment of technology advances in opioid drugs, as well as in non-narcotic drugs, which has revolutionized pain management by providing practical alternatives to opioids.
Assessment of factors driving the industry's growth, including market opportunities and restraints
Examination of product categories, clinical trials, new regulatory requirements and relevant patents
Coverage of market trends in undertreatment issues, professional issues, managed care pain issues, new therapies, product pipelines, generics, pain research and drug delivery
Company profiles of major players within the industry, including Abbott Laboratories, AbbVie Inc., Assertio Holdings Inc., Grunenthal GmbH, and Johnson & Johnson
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Highlights of the Market for Pain Management Drugs and Devices
Chapter 3 Market Overview
History of Pain and Pain Treatment
The Perception of Pain
Types of Pain
Acute Pain
Chronic Pain
Assessment of Pain
Subjective
Objective
How Pain is Diagnosed
How Pain is Treated
Physical Pain Treatment Modalities
Acupuncture/Acupressure
Ice (Cryotherapy)
Joint Mobilization
Manipulation
Massage
Traction
Radiation Therapy
Radio-Frequency Neuroablation and Epiduroscopy
Surgery
Whirlpool Bath (Thermotherapy)
Psychological Pain Therapies
Biofeedback
Hypnosis
Behavior Modification/Operant Conditioning
Relaxation and Stress Management Training
Imagery
Autogenic Training
Psychosocial Interventions
Distraction and Reframing
Chapter 4 Market Dynamics
Overview
Market Drivers
Market Restraints
Market Challenges
Chapter 5 Market Breakdown by Product
Market Overview
Market Share and Forecast
Pharmaceuticals
Narcotic Drugs
Non-narcotic Drugs
Antimigraine Drugs
Anesthesia Drugs
Other Drugs
Pain Management Devices
Neurostimulation Devices
Infusion Pumps
Ablation Devices
Chapter 6 Market Breakdown by Application
Market Overview
Market Share and Forecast
Musculoskeletal Pain
Post-operative Pain
Neuropathic Pain
Cancer Pain
Migraine/Headache
Other Applications
HIV/AIDS
Burn Pain
Dental Pain
Chapter 7 Market Breakdown by Region
Market Overview
Market Share Forecast
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Chapter 8 ESG Development
Introduction to ESG
Sustainability in the Pain Management Drugs and Devices Industry: An ESG Perspective
Key ESG Issues
ESG Ranking
Consumer Attitudes toward ESG in the Market for Pain Management Drugs and Devices
Case Study
Concluding Remarks from BCC
Chapter 9 Emerging Technologies
Overview
Technology Advancements in Opioid Drugs
Technology Advancements in Non-narcotic Drugs
Technology Advancements in Neuromodulation Devices
